SEARCH

SEARCH BY CITATION

References

  • 1
    Gold, R., Linington, C. and Lassmann, H., Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 2006. 129: 19531971.
  • 2
    Steinman, L. and Zamvil, S. S., How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis. Ann. Neurol. 2006. 60: 1221.
  • 3
    Rodriguez, M., Effectors of demyelination and remyelination in the CNS: implications for multiple sclerosis. Brain Pathol. 2007. 17: 219229.
  • 4
    Liblau, R. S., Singer, S. M. and McDevitt, H. O., Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today 1995. 16: 3438.
  • 5
    Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y. H., Wang, Y. et al., A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 2005. 6: 11331141.
  • 6
    Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T. et al., IL-23 drives a pathogenic T-cell population that induces autoimmune inflammation. J. Exp. Med. 2005. 201: 233240.
  • 7
    Steinman, L., A rush to judgment on Th17. J. Exp. Med. 2008. 205: 15171522.
  • 8
    Weiner, H. L., A shift from adaptive to innate immunity: a potential mechanism of disease progression in multiple sclerosis. J. Neurol. 2008. 255(Suppl 1): 311.
  • 9
    Schrempf, W. and Ziemssen, T., Glatiramer acetate: mechanisms of action in multiple sclerosis. Autoimmun. Rev. 2007. 6: 469475.
  • 10
    O'Connor, R. A. and Anderton, S. M., Foxp3+ regulatory T cells in the control of experimental CNS autoimmune disease. J. Neuroimmunol. 2008. 193: 111.
  • 11
    O'Connor, R. A., Prendergast, C. T., Sabatos, C. A., Lau, C. W., Leech, M. D., Wraith, D. C. and Anderton, S. M., Cutting edge: Th1 cells facilitate the entry of Th17 cells to the central nervous system during experimental autoimmune encephalomyelitis. J. Immunol. 2008. 181: 37503754.
  • 12
    Mensah-Brown, E. P., Shahin, A., Al Shamisi, M. and Lukic, M. L., Early influx of macrophages determines susceptibility to experimental allergic encephalomyelitis in Dark Agouti (DA) rats. J. Neuroimmunol. 2011. 232: 6874.
  • 13
    Tierney, J. B., Kharkrang, M. and La Flamme, A. C., Type II-activated macrophages suppress the development of experimental autoimmune encephalomyelitis. Immunol. Cell. Biol. 2009. 87: 235240.
  • 14
    Liew, F. Y., Pitman, N. I. and McInnes, I. B., Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat. Rev. Immunol. 2010. 10: 103110.
  • 15
    Schmitz, J., Owyang, A., Oldham, E., Song, Y., Murphy, E., McClanahan, T. K., Zurawski, G. et al., IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005. 23: 479490.
  • 16
    Carriere, V., Roussel, L., Ortega, N., Lacorre, D. A., Americh, L., Aguilar, L., Bouche, G. et al., IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc. Natl. Acad. Sci. USA. 2007. 104: 282287.
  • 17
    Luthi, A. U., Cullen, S. P., McNeela, E. A., Duriez, P. J., Afonina, I. S., Sheridan, C., Brumatti, G. et al., Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. Immunity 2009. 31: 8498.
  • 18
    Chackerian, A. A., Oldham, E. R., Murphy, E. E., Schmitz, J., Pflanz, S. and Kastelein, R. A., IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex. J. Immunol. 2007. 179: 25512555.
  • 19
    Yanagisawa, K., Tsukamoto, T., Takagi, T. and Tominaga, S., Murine ST2 gene is a member of the primary response gene family induced by growth factors. FEBS Lett. 1992. 302: 5153.
  • 20
    Werenskiold, A. K., Hoffmann, S. and Klemenz, R., Induction of a mitogen-responsive gene after expression of the Ha-ras oncogene in NIH 3T3 fibroblasts. Mol. Cell Biol. 1989. 9: 52075214.
  • 21
    Thomassen, E., Kothny, G., Haas, S., Danescu, J., Hultner, L., Dormer, P. and Werenskiold, A. K., Role of cell type-specific promoters in the developmental regulation of T1, an interleukin 1 receptor homologue. Cell Growth Differ. 1995. 6: 179184.
  • 22
    Xu, D., Chan, W. L., Leung, B. P., Huang, F., Wheeler, R., Piedrafita, D., Robinson, J. H. et al., Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells. J. Exp. Med. 1998. 187: 787794.
  • 23
    Kurowska-Stolarska, M., Kewin, P., Murphy, G., Russo, R. C., Stolarski, B., Garcia, C. C., Komai-Koma, M. et al., IL-33 induces antigen-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4. J. Immunol. 2008. 181: 47804790.
  • 24
    Humphreys, N. E., Xu, D., Hepworth, M. R., Liew, F. Y. and Grencis, R. K., IL-33, a potent inducer of adaptive immunity to intestinal nematodes. J. Immunol. 2008. 180: 24432449.
  • 25
    Miller, A. M., Xu, D., Asquith, D. L., Denby, L., Li, Y., Sattar, N., Baker, A. H. et al., IL-33 reduces the development of atherosclerosis. J. Exp. Med. 2008. 205: 339346.
  • 26
    Verri, W. A., Jr., Guerrero, A. T., Fukada, S. Y., Valerio, D. A., Cunha, T. M., Xu, D., Ferreira, S. H. et al., IL-33 mediates antigen-induced cutaneous and articular hypernociception in mice. Proc. Natl. Acad. Sci. USA 2008. 105: 27232728.
  • 27
    Xu, D., Jiang, H. R., Kewin, P., Li, Y., Mu, R., Fraser, A. R., Pitman, N. et al., IL-33 exacerbates antigen-induced arthritis by activating mast cells. Proc. Natl. Acad. Sci. USA 2008. 105: 1091310918.
  • 28
    Kurowska-Stolarska, M., Stolarski, B., Kewin, P., Murphy, G., Corrigan, C. J., Ying, S., Pitman, N. et al., IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation. J. Immunol. 2009. 183: 64696477.
  • 29
    Miller, A. M., Asquith, D. L., Hueber, A. J., Anderson, L. A., Holmes, W. M., McKenzie, A. N., Xu, D. et al., Interleukin-33 induces protective effects in adipose tissue inflammation during obesity in mice. Circ. Res. 2010. 107: 650658.
  • 30
    Andre, R., Lerouet, D., Kimber, I., Pinteaux, E. and Rothwell, N. J., Regulation of expression of the novel IL-1 receptor family members in the mouse brain. J. Neurochem. 2005. 95: 324330.
  • 31
    Hudson, C. A., Christophi, G. P., Gruber, R. C., Wilmore, J. R., Lawrence, D. A. and Massa, P. T., Induction of IL-33 expression and activity in central nervous system glia. J. Leukoc. Biol. 2008. 84: 631643.
  • 32
    Christophi, G. P., Gruber, R. C., Panos, M., Christophi, R. L., Jubelt, B. and Massa, P. T., Interleukin-33 upregulation in peripheral leukocytes and CNS of multiple sclerosis patients. Clin. Immunol. 2012. 142: 308319.
  • 33
    Gordon, S., Alternative activation of macrophages. Nat. Rev. Immunol. 2003. 3: 2335.
  • 34
    Mikita, J., Dubourdieu-Cassagno, N., Deloire, M. S., Vekris, A., Biran, M., Raffard, G., Brochet, B. et al., Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administration. Mult. Scler. 2010. 17: 215.
  • 35
    Huber, S., Hoffmann, R., Muskens, F. and Voehringer, D., Alternatively activated macrophages inhibit T-cell proliferation by Stat6-dependent expression of PD-L2. Blood 2010. 116: 33113320.
  • 36
    Yasuoka, S., Kawanokuchi, J., Parajuli, B., Jin, S., Doi, Y., Noda, M., Sonobe, Y. et al., Production and functions of IL-33 in the central nervous system. Brain Res. 2011. 1385: 817.
  • 37
    Chapuis, J., Hot, D., Hansmannel, F., Kerdraon, O., Ferreira, S., Hubans, C., Maurage, C. A. et al., Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease. Mol. Psychiatry 2009. 14: 10041016.
  • 38
    Segal, B. M., Experimental autoimmune encephalomyelitis: cytokines, effector T cells, and antigen-presenting cells in a prototypical Th1-mediated autoimmune disease. Curr. Allergy Asthma Rep. 2003. 3: 8693.
  • 39
    Coyle, A. J., Lloyd, C., Tian, J., Nguyen, T., Erikkson, C., Wang, L., Ottoson, P. et al., Crucial role of the interleukin 1 receptor family member T1/ST2 in T helper cell type 2-mediated lung mucosal immune responses. J. Exp. Med. 1999. 190: 895—902.
  • 40
    Wraith, D. C., Nicolson, K. S. and Whitley, N. T., Regulatory CD4+ T cells and the control of autoimmune disease. Curr. Opin. Immunol. 2004. 16: 695701.
  • 41
    Turnquist, H. R., Zhao, Z., Rosborough, B. R., Liu, Q., Castellaneta, A., Isse, K., Wang, Z. et al., IL-33 expands suppressive CD11b+ Gr-1int and regulatory T Cells, including ST2L+ Foxp3+ cells, and mediates regulatory T cell-dependent promotion of cardiac allograft survival. J. Immunol. 2011. 187: 45984610.
  • 42
    Oboki, K., Ohno, T., Kajiwara, N., Arae, K., Morita, H., Ishii, A., Nambu, A. et al., IL-33 is a crucial amplifier of innate rather than acquired immunity. Proc. Natl. Acad. Sci. USA 2010. 107: 1858118586.
  • 43
    Brint, E. K., Xu, D., Liu, H., Dunne, A., McKenzie, A. N., O’Neill, L. A. and Liew, F. Y., ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance. Nat. Immunol. 2004. 5: 373379.